Abstract:Immunochemotherapy remodelled T‐cell phenotypes. For the patients achieving a complete response, more interferon‐gamma was provided by CD8+ T cells after therapy, which would be the key for TAMs pro‐inflammatory repolarization and eventually promote the CD8+ T cells maturation in turns. Among patients who did not reach a complete response, malignant cells exhibited higher levels of immune checkpoint genes before therapy, and decreased tumour antigen presentation activity, which may underlie the resistance mechanism to therapy. Background Combinatory therapeutic strategy containing immunochemotherapy as part of induction therapy components is one of the current trends in the treatment of high‐risk metastatic locally advanced nasopharyngeal carcinoma (NPC). However, the mechanism underlying the heterogeneity of response at the single‐cell level has not been underexplored. Methods 18 bulks and 11 single‐cell RNA sequencing from paired before‐treatment and on‐treatment samples in patients with treatment‐naive high‐risk metastatic locally advanced NPCs were obtained. Following quality control, a total of 87 191 cells were included in the subsequence bioinformatics analysis. Results Immunochemotherapy was associated with on‐treatment tumour microenvironment (TME) remodelling, including upregulation of anti‐TMEs signatures, downregulation of pro‐TMEs signatures, reversing CD8+ T exhaustion, and repolarizing proinflammatory TAMs. For the patients achieving a complete response, the cytotoxic activity of CD8+ T cells was stimulated and more interferon‐gamma was provided, which would be the key for TAMs proinflammatory repolarization and eventually promote the CD8+ T cells maturation in turn. Among patients who did not reach complete response, differentiation and hypoxia signatures for endothelial cells were elevated after therapy. These patients exhibited higher levels of immune checkpoint genes in malignant cells at the baseline (before treatment), and decreased tumour antigen presentation activity, which may underlie the resistance mechanism to therapy. Conclusions This study pictures a map of TME modulation following immunochemotherapy‐based combination induction therapy and provides potential future approaches. Highlights Immunochemotherapy remodeled T cell phenotypes. For the patients achieving complete response, more interferon gamma was provided by CD8+ T cells after therapy, which would be the key for TAMs pro‐inflammatory repolarization and eventually promote the CD8+ T cells maturation in turns. Among patients who did not reach complete response, malignant cells exhibited higher level of immune checkpoint genes before therapy, and decreased tumor antigen presentation activity, which may underlie the resistance mechanism to therapy.

Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses

Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma

Identification of Prognostic Biomarkers for Response to Radiotherapy by DNA Microarray in Nasopharyngeal Carcinoma Patients

Tumour heterogeneity and intercellular networks of nasopharyngeal carcinoma at single cell resolution

Multimodal profiling uncovers tertiary lymphoid structures as a critical determinant of immunotherapy response and prognosis in nasopharyngeal carcinoma

Dissecting the heterogeneity of the microenvironment in primary and recurrent nasopharyngeal carcinomas using single-cell RNA sequencing

Single‐cell analysis reveals the multiple patterns of immune escape in the nasopharyngeal carcinoma microenvironment

Comprehensive single-cell sequencing reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of nasopharyngeal carcinoma

Single‐cell transcriptome analysis reveals evolving tumour microenvironment induced by immunochemotherapy in nasopharyngeal carcinoma

Prognosis-related Molecular Subtyping of Nasopharyngeal Carcinoma

An immune-related prognostic model predicts neoplasm-immunity interactions for metastatic nasopharyngeal carcinoma

Exploration of spatial heterogeneity of tumor microenvironment in nasopharyngeal carcinoma via transcriptional digital spatial profiling

Development and validation of an immune checkpoint-based signature to predict prognosis in nasopharyngeal carcinoma using computational pathology analysis

Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes

Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics

Peripheral NK-cell immunophenotypes predict progression in nasopharyngeal carcinoma patients.

An individualized immune prognostic signature in nasopharyngeal carcinoma

Identification of markers for predicting prognosis and endocrine metabolism in nasopharyngeal carcinoma by miRNA-mRNA network mining and machine learning

Neoantigen landscape in metastatic nasopharyngeal carcinoma

Prognostic stratification of patients with nasopharyngeal carcinoma based on tumor immune microenvironment

Radiomic signatures associated with tumor immune heterogeneity predict survival in locally recurrent nasopharyngeal carcinoma